The development of a novel therapy using glycyrrhitinic acid for overactive bladder caused by lower urinary tract obstruction.
Not Applicable
- Conditions
- overactive bladder caused by lower urinary tract obstruction
- Registration Number
- JPRN-UMIN000001912
- Lead Sponsor
- rology, Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Central nervous system disease (2) Underactive bladder (3) Active UTI (4) active urothelial or prostatic cancer (5) maintained on anticholinergics (6) severe cardiac or renal dysfunction (7) maintained on diuretics (8) maintained on moxyfloxacin (9) serum K <3.5 (10) judged inelligible by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The improvement of IPSS and OABSS compared with pre-thrapeutic data
- Secondary Outcome Measures
Name Time Method